Huping Wu

Dr. Huping Wu


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2022 in Frontiers in Medicine
Verified
Journal Article
Open access
YZYanlin Zhong
Yanlin Zhong
XFXie Fang
Xie Fang
XWXuemei Wang
Xuemei Wang
YLYu-An Lin
Yu-An Lin
HWHuping Wu
Huping Wu
CLCheng Li
Cheng Li
Purpose: This study aimed to determine the composition and diversity of bacterial communities on the ocular surface before and after the intervention with sodium hyaluronate eye drops (with or without preservatives) using 16S rRNA gene amplicon sequencing.Methods: Sixteen healthy adults were randomly divided into two groups and treated with sodium hyaluronate eye drops with or without preservatives for 2 weeks. The individuals used the same artificial tears in both eyes. The microbial samples from the conjunctival sac of each participant were collected at baseline and 2 weeks after intervention. The diversity and taxonomic differences among different groups before and after intervention were compared by sequencing the V3–V4 region of the 16S rRNA gene.Results: The similarity in the binocular microbial community was high in 1 of the 16 volunteers (Bray-Curtis dissimilarity score < 0.3). At the genus level, 11 bacteria were detected in all samples with an average relative abundance of more than 1%. The bacterial community changed significantly after the use of sodium hyaluronate eye drops (with or without preservatives), whether within individuals or between individuals in different groups (P < 0.05, PERMANOVA). Different dosage forms of sodium hyaluronate eye drops significantly decreased the relative abundance of Flavobacterium caeni and Deinococcus antarcticus, respectively (P < 0.05).Conclusions: Healthy people had a rich diversity of the bacterial microbiota on the ocular surface, but the bacterial communities between the eyes were not completely similar. Irrespective of containing benzalkonium chloride (BAC), sodium hyaluronate eye drops can change the bacterial community on the ocular surface.

9 March 2020 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Open access
PDF file
HHHuan He
Huan He
MLMinghui Liang
Minghui Liang
LLLan Li
Lan Li
SLShunrong Luo
Shunrong Luo
XFXie Fang
Xie Fang
ZLZhirong Lin
Zhirong Lin
Purpose: To investigate the effects and mechanisms of the peroxisome proliferator-activated receptor alpha (PPAR-α) agonist fenofibrate on the formation of ocular surface squamous metaplasia induced by topical benzalkonium chloride (BAC) in a mouse model. Methods: Ocular surface squamous metaplasia was induced in 16 days by topical BAC application in mice. During the period of induction, mice were divided into four groups: no additional treatment (BAC+UT), topical vehicle (BAC+Vehicle), topical fenofibrate (BAC+Feno), or topical fenofibrate plus intraperitoneal injection of MK886 (BAC+Feno+MK886). The parameters of tear film were evaluated on day 16, and eye specimens were collected. Histologic investigation; PAS assays; immunostaining for cytokeratin 10 (K10), Ki67, and F4/80; and PCR assays for TNF-α and IL-6 were performed. Cell Counting Kit 8 (CCK-8) assays were performed to evaluate the inhibitory effects of fenofibrate on RAW264.7 cells. Results: Fenofibrate suppressed the formation of BAC-induced instable tear film. In the BAC+Feno group, the expression of K10 and Ki67 was lower than in the other three groups. The number of goblet cells was reduced in eyes of the BAC+UT and BAC+Vehicle groups but was maintained in eyes of the BAC+Feno group. The number of F4/80-positive cells and the levels of TNF-α and IL-6 mRNA were significantly reduced in the cornea of the BAC+Feno group. These effects of fenofibrate could be attenuated by MK886. The cell viability of RAW264.7 cells could be significantly inhibited by fenofibrate in a dose-dependent pattern. Conclusions: Topical application of fenofibrate suppressed the formation of ocular surface squamous metaplasia, which might be mediated through the PPAR-α signaling pathway.

2 October 2022 in Journal of Histotechnology
Verified
Journal Article
Open access
YZYujie Zhang
Yujie Zhang
XFXie Fang
Xie Fang
ZLZhirong Lin
Zhirong Lin
ZXZhiwen Xie
Zhiwen Xie
HWHuping Wu
Huping Wu
Ou OuOu Ou
Ou Ou
Mooren’s ulcer (MU) is a chronic and painful ulcerative keratitis that is difficult to diagnose, especially when concealed beneath the pterygium, which is a common, benign, wedge-shaped, fleshy tissue growth of the conjunctiva extending onto the cornea. The coexistence of MU and pterygium is extremely rare. A 41-year-old man presented with a 2-month history of unprovoked redness, pain, and blurred vision in the right eye. Corneal epithelial defects around the pterygium head were noted upon slit-lamp examination and fluorescein staining. The patient was initially misdiagnosed with a corneal epithelial defect and pterygium. The initial treatments with anti-inflammatory and corneal epithelial growth promotion tear agents failed. Anterior segment optical coherence tomography (AS-OCT) showed corneal stromal lysis thinning, and in vivo confocal microscopy (IVCM) revealed marked inflammatory cell infiltration and stromal degeneration. We suspected the pathology was an immune-related or tumor-related corneal ulcer. The MU concealed beneath the pterygium was diagnosed by histopathological examination of a biopsy specimen that presented typical localized loss of the corneal epithelium and Bowman’s layer, stromal degeneration, and inflammatory cell infiltration. Finally, we performed lamellar keratoplasty (LKP) combined with pterygium excision surgery. The patient recovered with no complications or recurrence during the 1-year follow-up period. Few cases of MU concealed beneath the pterygium have been reported. It is beneficial to rule out the pathological changes concealed beneath the pterygium, combined with multiple means of examination such as slit-lamp examination, AS-OCT, and IVCM. A histopathological examination should be performed to establish a diagnosis.

28 June 2024 in Heliyon
Verified
Journal Article
Open access
HLHanqiao Li
Hanqiao Li
LHLi Huang
Li Huang
XFXie Fang
Xie Fang
ZXZhiwen Xie
Zhiwen Xie
XXXianwen Xiao
Xianwen Xiao
HWHuping Wu
Huping Wu
The treatment and management of ocular surface diseases have shifted towards a co-treatment approach focusing on overall ocular surface homeostasis. When treating issues related to the eye, it is essential to not only focus on the damaged or disabled areas but also consider the larger picture. Meibomian gland dysfunction (MGD), Demodex infection, and blepharitis all interact at the eyelid site and can cause damage to the ocular surface to varying degrees. Palpebral lesions disrupt the balance of ocular surface homeostasis, leading to dry eye and keratitis. Traditional treatments, such as manual physical hot compress massage, have limited effectiveness due to the structure of the eyelid. However, intense pulsed light (IPL) technology uses penetrating light energy to generate heat energy, which can eliminate inflammation of capillaries or kill Demodex. Additionally, the LipiFlow thermal effect and physical compression provide a more vital and longer-lasting therapeutic effect on MGD by excluding other primary causes of ocular surface inflammation. Therefore, personalized treatment techniques based on photothermal effects may be effective. In the future, IPL and LipiFlow may potentially dismiss immune-inflammation factors causing ocular surface disease or block the delivery of systemic immune-related diseases.

31 August 2023 in Frontiers in Medicine
Verified
Journal Article
Open access
YLYuan Lin
Yuan Lin
YZYujie Zhang
Yujie Zhang
KSKe Shi
Ke Shi
HWHuping Wu
Huping Wu
Ou OuOu Ou
Ou Ou
In humans, the lacrimal gland is located in the socket of the frontal bone above the outer orbital area. As an essential part of the eye surface, the gland is fixed to the orbital periosteum by connective tissue. The lacrimal gland passes through the outer tendon membrane, which divides the gland into larger orbital and minor eyelid glands. The lacrimal glands are the main contributors to tear film. They secrete electrolytes, proteins, and water to help nourish and protect the eye’s surface. Furthermore, clinically, lacrimal glands are associated with a variety of inflammatory reactions and immune factors and are also vulnerable sites for tumors. Changes in tear gland morphology or secretory function affect tear film stability and tear secretion quality. Various technological devices have been developed and applied to lacrimal glands. This article systematically reviewed the clinical examination of the lacrimal gland to help inform personalized strategies for the diagnosis of lacrimal gland-related diseases.

11 November 2025 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
SOShangkun Ou
Shangkun Ou
YZYujie Zhang
Yujie Zhang
YFYuchong Feng
Yuchong Feng
XZXueer Zheng
Xueer Zheng
YLYuan Lin
Yuan Lin
Yiming WuYiming Wu
Yiming Wu
Mooren’s Ulcer (MU) is a rare, chronic, and painful form of autoimmune peripheral ulcerative keratitis (PUK), with an elusive etiology and a risk of corneal perforation and vision loss. Despite numerous proposed triggers, including parasitic infections, hepatitis C virus, ocular trauma, and surgery, the pathogenesis of MU remains unclear, and diagnosis continues to rely heavily on exclusion. A key controversy in current clinical practice lies in the absence of standardized diagnostic criteria and consensus treatment protocols. This review addresses this gap by presenting a comprehensive and structured diagnostic framework for MU, particularly emphasizing laboratory and immunological testing strategies to facilitate accurate differential diagnosis. To our knowledge, this is the first review to systematize these diagnostic components in detail. In addition to summarizing the latest findings on epidemiology, etiology, pathology, and classification, the work also review the evolving role of advanced imaging, histopathology, and tear-based markers in MU diagnosis and monitoring. Treatment options, ranging from immunosuppressive therapy to surgical intervention, are discussed based on disease severity. This work recommend a tiered, individualized approach to treatment and advocate for future multicenter studies to validate diagnostic protocols and establish evidence-based clinical guidelines.